Kaisha Pharma has established Kaisha Pharma International in Italy as its global business development and customer support hub, marking the next step in the company’s international expansion strategy following its recent launch.

Based in Italy, the new entity will oversee strategic customer outreach, market engagement and business development across international markets, including the Americas, Europe, Middle East and Africa (EMEA), and Asia-Pacific. It will also manage customer relationships and support for the company’s pharmaceutical and biotechnology customers globally.

The establishment of Kaisha Pharma International follows an initial Euro 45 million capital deployment in Kaisha Pharma, announced as part of a multi-million-euro long-term investment programme. The investment is intended to support the company’s global expansion, advanced manufacturing capabilities, technology partnerships and development of next-generation pharmaceutical packaging solutions.

Kaisha Pharma has appointed Andrea Zambon as Managing Director of Kaisha Pharma International and Global Head of International Business Development. In his role, Zambon will lead the company’s international business development activities and customer engagement across global markets.

Kairus Dadachanji, Managing Director, Kaisha Pharma, said the establishment of the Italy-based entity represents another milestone in the company’s plans to build a global pharmaceutical packaging business.

Rishad Dadachanji, Director, Kaisha Pharma, said Italy’s position as a major pharmaceutical manufacturing and innovation centre makes it a strategic location for the company’s international business development operations.

Andrea Zambon said his appointment comes at a stage of significant development for Kaisha Pharma and highlighted the company’s focus on investment, technology and customer partnerships in the pharmaceutical packaging sector.